LH

LH

USD

Labcorp Holdings Inc. Common Stock

$252.720+5.880 (2.382%)

Prix en Temps Réel

Healthcare
Diagnostics & Research
États-Unis

Graphique des Prix

Loading Chart...

Métriques Clés

Métriques de Marché
Fondamentaux de l'Entreprise
Statistiques de Trading

Métriques de Marché

Ouverture

$246.840

Haut

$252.760

Bas

$244.520

Volume

0.69M

Fondamentaux de l'Entreprise

Capitalisation Boursière

21.0B

Industrie

Diagnostics & Research

Pays

United States

Statistiques de Trading

Volume Moyen

0.62M

Bourse

NYQ

Devise

USD

Intervalle sur 52 Semaines

Bas $209.38Actuel $252.720Haut $293.72

Actualités Connexes

Analyst Upgrades

UBS Maintains Buy on Labcorp Hldgs, Lowers Price Target to $320

UBS analyst Kevin Caliendo maintains Labcorp Hldgs with a Buy and lowers the price target from $325 to $320.

Voir plus
UBS Maintains Buy on Labcorp Hldgs, Lowers Price Target to $320
Reuters

Labcorp cuts growth outlook for research unit as biotech funding crunch persists

Labcorp forecast lower annual revenue growth for its contract research unit on Tuesday, as a prolonged funding crunch continues to weigh on its early-stage drug development clients.

Voir plus
Labcorp cuts growth outlook for research unit as biotech funding crunch persists
Analyst Upgrades

Labcorp Positioned For Gradual Upside With Resilient Margins And Dividend Support

Labcorp posts Q3 EPS of $4.18 and sales of $3.56 billion, exceeding estimates, while revising 2025 guidance amid strong diagnostics and lab growth.

Voir plus
Labcorp Positioned For Gradual Upside With Resilient Margins And Dividend Support
PR Newswire

Labcorp Announces 2025 Third Quarter Results

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced results for the third quarter ended...

Voir plus
Labcorp Announces 2025 Third Quarter Results
PR Newswire

Labcorp to Offer First FDA-Cleared Blood Test to Rule out Alzheimer's-Related Amyloid Pathology in Primary Care Settings

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today it will offer the Elecsys pTau181 test, the...

Voir plus
Labcorp to Offer First FDA-Cleared Blood Test to Rule out Alzheimer's-Related Amyloid Pathology in Primary Care Settings

Restez Informé

Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.